1-4 of 4
Robert L. Sutherland
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cyclin E2 Overexpression Is Associated with Endocrine Resistance but not Insensitivity to CDK2 Inhibition in Human Breast Cancer Cells

Free
C. Elizabeth Caldon, C. Marcelo Sergio, Jian Kang, Anita Muthukaruppan, Marijke N. Boersma, Andrew Stone, Jane Barraclough, Christine S. Lee, Michael A. Black, Lance D. Miller, Julia M. Gee, Rob I. Nicholson, Robert L. Sutherland, Cristin G. Print, Elizabeth A. Musgrove
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (7): 1488–1499.
https://doi.org/10.1158/1535-7163.MCT-11-0963
Published: 05 July 2012
View article titled, Cyclin E2 Overexpression Is Associated with Endocrine Resistance but not Insensitivity to CDK2 Inhibition in Human Breast Cancer Cells
Open the PDF for Cyclin E2 Overexpression Is Associated with Endocrine Resistance but not Insensitivity to CDK2 Inhibition in Human Breast Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Synergistic cytotoxicity between tamoxifen and the plant toxin persin in human breast cancer cells is dependent on Bim expression and mediated by modulation of ceramide metabolism

Free
Caroline G. Roberts, Ebru Gurisik, Trevor J. Biden, Robert L. Sutherland, Alison J. Butt
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (10): 2777–2785.
https://doi.org/10.1158/1535-7163.MCT-07-0374
Published: 15 October 2007
View article titled, Synergistic cytotoxicity between tamoxifen and the plant toxin persin in human breast cancer cells is dependent on Bim expression and mediated by modulation of ceramide metabolism
Open the PDF for Synergistic cytotoxicity between tamoxifen and the plant toxin persin in human breast cancer cells is dependent on Bim expression and mediated by modulation of ceramide metabolism in another window
Journal Articles

A novel plant toxin, persin, with in vivo activity in the mammary gland, induces Bim-dependent apoptosis in human breast cancer cells

Free
Alison J. Butt, Caroline G. Roberts, Alan A. Seawright, Peter B. Oelrichs, John K. MacLeod, Tracy Y.E. Liaw, Maria Kavallaris, Tiffany J. Somers-Edgar, Gillian M. Lehrbach, Colin K. Watts, Robert L. Sutherland
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (9): 2300–2309.
https://doi.org/10.1158/1535-7163.MCT-06-0170
Published: 19 September 2006
View article titled, A novel plant toxin, persin, with in vivo activity in the mammary gland, induces Bim-dependent apoptosis in human breast cancer cells
Open the PDF for A novel plant toxin, persin, with in vivo activity in the mammary gland, induces Bim-dependent apoptosis in human breast cancer cells in another window
Journal Articles

Preclinical validation of anti-TMEFF2-auristatin E–conjugated antibodies in the treatment of prostate cancer

Free
Daniel E.H. Afar, Vinay Bhaskar, Eric Ibsen, Danna Breinberg, Susan M. Henshall, James G. Kench, Marija Drobnjak, Rick Powers, Melanie Wong, Ferdinand Evangelista, Chris O'Hara, David Powers, Robert B. DuBridge, Ingrid Caras, Ruth Winter, Terri Anderson, Nanette Solvason, Phillip D. Stricker, Carlos Cordon-Cardo, Howard I. Scher, John J. Grygiel, Robert L. Sutherland, Richard Murray, Vanitha Ramakrishnan, Debbie A. Law
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2004) 3 (8): 921–932.
https://doi.org/10.1158/1535-7163.921.3.8
Published: 06 August 2004
View article titled, Preclinical validation of anti-TMEFF2-auristatin E–conjugated antibodies in the treatment of prostate cancer
Open the PDF for Preclinical validation of anti-TMEFF2-auristatin E–conjugated antibodies in the treatment of prostate cancer in another window